| Financial Year |
March 31 2023 |
| Monetary Funds |
121,767,319.53 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
3,656,000.00 |
| Accounts Receivable |
178,893,272.07 |
| Advances to Suppliers |
3,361,009.96 |
| Other Receivables |
4,815,454.04 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
-- |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,504,980.42 |
| Total Current Assets |
805,396,824.15 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
85,133,751.00 |
| Investment Properties |
3,756,620.80 |
| Fixed Assetes |
164,794,291.40 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
679,200.46 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
16,931,580.01 |
| Other Non-Current Assets |
5,000,000.00 |
| Sub-Total of Non-Current Assets |
295,579,190.31 |
| Total Assets |
1,100,976,014.46 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
515,175,997.92 |
| Accounts Received In Advance |
7,500.00 |
| Employee Compensation Payable |
3,022,331.86 |
| Taxes Payable |
12,022,244.60 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
16,112,419.47 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,304,674.09 |
| Other Current Liabilities |
13,901.49 |
| Sub-Total of Current Liabilities |
550,708,985.42 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
316,338.48 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
443,322.60 |
| Total Liabilities |
551,152,308.02 |
| Paid-In Capital(Or Share Stock) |
132,416,609.00 |
| Capital Surplus |
128,089,305.51 |
| Surplus Reserve |
43,213,614.23 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
245,209,736.81 |
| Minority Stockholder's Interest |
894,440.89 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
548,929,265.55 |
| Owner's Equity（Stockholder's Equity） |
549,823,706.44 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,100,976,014.46 |
